Towa, Kyoto iPS Upstart Eye Repositioning of Generic Drug for Alzheimer’s

Japanese generic major Towa Pharmaceutical and Kyoto-based Time Therapeutics are aiming to repurpose a generic drug, bromocriptine, for the treatment of familial Alzheimer’s disease based on iPS cell-based drug discovery assays, the two companies said on August 26. The two...read more